Medications in long-term care: when less is more
- PMID: 21641504
- DOI: 10.1016/j.cger.2011.01.003
Medications in long-term care: when less is more
Abstract
Attention has been drawn to the potential risks of several medications in the long-term care setting. Most of these medications deemed as inappropriate affect the central nervous system and are indicated only for select populations with specific conditions. Many of these drugs are prescribed without clear indications and continued indefinitely without critical decision-making about the potentially salutary effects of discontinuing medications. This article describes the increasing awareness of potentially inappropriate prescribing in the long-term care setting and reviews the rationale for why various types of medications are deemed inappropriate, with a focus on agents that affect central nervous system functioning.
Copyright © 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
National trends in psychotropic medication polypharmacy in office-based psychiatry.Arch Gen Psychiatry. 2010 Jan;67(1):26-36. doi: 10.1001/archgenpsychiatry.2009.175. Arch Gen Psychiatry. 2010. PMID: 20048220
-
How well do psychotropic medications match mental health diagnoses? A national view of potential off-label prescribing in VHA nursing homes.Age Ageing. 2007 Jan;36(1):107-8; author reply 108-9. doi: 10.1093/ageing/afl131. Epub 2006 Dec 6. Age Ageing. 2007. PMID: 17158114 No abstract available.
-
Potentially inappropriate prescribing including under-use amongst older patients with cognitive or psychiatric co-morbidities.Age Ageing. 2010 May;39(3):373-81. doi: 10.1093/ageing/afq031. Epub 2010 Apr 7. Age Ageing. 2010. PMID: 20378571
-
Reducing the risk of adverse drug events in older adults.Am Fam Physician. 2013 Mar 1;87(5):331-6. Am Fam Physician. 2013. PMID: 23547549 Review.
-
Polypharmacy in the elderly: maximizing benefit, minimizing harm.Crit Care Nurs Q. 2008 Jan-Mar;31(1):40-5. doi: 10.1097/01.CNQ.0000306395.86905.8b. Crit Care Nurs Q. 2008. PMID: 18316935 Review.
Cited by
-
An Internationally Derived Process of Healthcare Professionals' Proactive Deprescribing Steps and Constituent Activities.Pharmacy (Basel). 2024 Sep 9;12(5):138. doi: 10.3390/pharmacy12050138. Pharmacy (Basel). 2024. PMID: 39311129 Free PMC article.
-
Predictors of Adverse Drug Reaction-Related Hospitalisations Among People with Dementia: A Retrospective Case-Control Study.Drug Saf. 2024 Aug;47(8):771-781. doi: 10.1007/s40264-024-01435-3. Epub 2024 May 13. Drug Saf. 2024. PMID: 38739234 Free PMC article.
-
Melatonin and melatonin agonist for delirium in the elderly patients.Am J Alzheimers Dis Other Demen. 2015 Mar;30(2):119-29. doi: 10.1177/1533317514539379. Epub 2014 Jun 18. Am J Alzheimers Dis Other Demen. 2015. PMID: 24946785 Free PMC article. Review.
-
Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process.Br J Clin Pharmacol. 2014 Oct;78(4):738-47. doi: 10.1111/bcp.12386. Br J Clin Pharmacol. 2014. PMID: 24661192 Free PMC article.
-
Patient barriers to and enablers of deprescribing: a systematic review.Drugs Aging. 2013 Oct;30(10):793-807. doi: 10.1007/s40266-013-0106-8. Drugs Aging. 2013. PMID: 23912674 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
